SS
HALO icon

SBI Securities’s Halozyme HALO Stock Holding History

SBI Securities’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.4K Buy
504
+104
+26% +$7.09K ﹤0.01% 1261
2026
Q1 		$25.9K Sell
400
-1,047
-72% -$73.8K ﹤0.01% 1353
2025
Q4 		$97.4K Buy
1,447
+1,128
+354% +$75.9K ﹤0.01% 861
2025
Q3 		$23.4K Buy
319
+103
+48% +$6.84K ﹤0.01% 1382
2025
Q2 		$11.2K Sell
216
-152
-41% -$8.65K ﹤0.01% 1655
2025
Q1 		$23.5K Buy
368
+168
+84% +$9.76K ﹤0.01% 1265
2024
Q4 		$9.56K Buy
+200
New +$10.3K ﹤0.01% 1665

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SBI Securities's HALO Position: Q2 2026 in Review

SBI Securities increased its Halozyme (HALO) stake by 26% in Q2 2026, buying an estimated $7.09K and bringing the position to 504 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

SBI Securities first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. The position peaked at $97.4K in Q4 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • SBI Securities held 504 shares of Halozyme worth $39.4K as of Q2 2026.
  • SBI Securities bought 104 Halozyme shares in Q2 2026, an estimated $7.09K.
  • Halozyme made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1261 holding.
  • SBI Securities first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Halozyme position peaked at $97.4K in Q4 2025.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.